213 related articles for article (PubMed ID: 11717742)
1. [Antiestrogens--benefits of estrogens without their disadvantages?].
Välimäki MJ; Tiitinen A
Duodecim; 1998; 114(19):1885, 1887-8. PubMed ID: 11717742
[No Abstract] [Full Text] [Related]
2. [The modulators of the estrogenic activity].
Kirkiacharian S
Ann Pharm Fr; 2000 Dec; 58(6):383-91. PubMed ID: 11148373
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
Jordan VC
J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
[No Abstract] [Full Text] [Related]
4. Antiestrogens: the past and the future.
Bentrem DJ; Jordan VC
Zentralbl Gynakol; 2002 Dec; 124(12):551-8. PubMed ID: 12822068
[No Abstract] [Full Text] [Related]
5. [Raloxifene hydrochloride].
Itabashi A
Nihon Rinsho; 2004 Feb; 62 Suppl 2():528-35. PubMed ID: 15035185
[No Abstract] [Full Text] [Related]
6. The science of selective estrogen receptor modulators: concept to clinical practice.
Jordan VC
Clin Cancer Res; 2006 Sep; 12(17):5010-3. PubMed ID: 16951214
[No Abstract] [Full Text] [Related]
7. Raloxifene.
Gass ML
South Med J; 1999 Nov; 92(11):1120-3. PubMed ID: 10586846
[No Abstract] [Full Text] [Related]
8. Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?
Mayeux R
N Engl J Med; 2001 Apr; 344(16):1242-4. PubMed ID: 11309641
[No Abstract] [Full Text] [Related]
9. [Selective estrogen receptor modulators (SERMs) in the practice].
Nagykálnai T
Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
[TBL] [Abstract][Full Text] [Related]
10. Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.
Riggs BL; Hartmann LC
N Engl J Med; 2003 Feb; 348(7):618-29. PubMed ID: 12584371
[No Abstract] [Full Text] [Related]
11. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
Ohta H
Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen, raloxifene and the prevention of breast cancer.
Bentrem DJ; Craig Jordan V
Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene: another selective estrogen modulator.
Kellen JA
In Vivo; 2001; 15(6):459-60. PubMed ID: 11887329
[TBL] [Abstract][Full Text] [Related]
14. Defining the role of raloxifene for the prevention of breast cancer.
Kalidas M; Hilsenbeck S; Brown P
J Natl Cancer Inst; 2004 Dec; 96(23):1731-3. PubMed ID: 15572750
[No Abstract] [Full Text] [Related]
15. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
Vogelvang TE; Mijatovic V; van der Mooren MJ; Pinsdorf U; von Bergmann K; Netelenbos JC; Lütjohann D
Maturitas; 2005 Apr; 50(4):312-20. PubMed ID: 15780532
[TBL] [Abstract][Full Text] [Related]
16. Raloxifene: bone and cardiovascular effects.
Francucci CM; Romagni P; Boscaro M
J Endocrinol Invest; 2005; 28(10 Suppl):85-9. PubMed ID: 16550730
[TBL] [Abstract][Full Text] [Related]
17. [Antiestrogens: mechanism of action and clinical applications].
Barrón-González A; Arias-Martínez J; Castro-Romero I
Salud Publica Mex; 2001; 43(6):577-84. PubMed ID: 11816234
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen-receptor modulators for primary prevention of breast cancer.
Fabian CJ; Kimler BF
J Clin Oncol; 2005 Mar; 23(8):1644-55. PubMed ID: 15755972
[No Abstract] [Full Text] [Related]
19. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
Maeda T; Ke HZ; Simmons H; Thompson D
Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
Jordan VC
J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
